![Zorbtive [somatropin (rDNA origin) for injection]](images/Zorbtive_180.png)
How SeroCareSM
can help Zorbtive patients
Helpful information for people with SBS considering Zorbtive treatment
Clinical information about Zorbtive for health professionals
Clinical opinions about Zorbtive and goals of treatment for Short Bowel Syndrome
SBS-experienced clinicians have published the following statements.
“In this study, growth hormone and a specialized oral diet including glutamine reduced and maintained average infusion time to one to two days per week from a previous schedule of five to six days per week.”
— |
Theresa A. Byrne, DSc Annals of Surgery, 2005 |
“The goal of medical therapy for (SBS) patients is to resume a lifestyle as near normal as possible via the use of specific measures to gradually decrease PN requirement and, at best, to eliminate its need.”
—
|
Alan Buchman, MD, MSPH Gastroenterology 2003 |
“A reduction in parenteral nutrition use will most likely improve the (SBS) patient’s quality of life and may result in some reduction in the (health) risks associated with PN.”
—
|
Ezra Steiger, MD, FACS, CNSP Journal of Clinical Gastroenterology May/June 2006 |
“Most important (for prevention of PN-associated liver disease), oral intake should be maximized and PN minimized.”
—
|
Laura Matarese, MS, RD, FADA,
CNSD Intestinal Failure and Rehabilitation: A Clinical Guide published 2005 |
How SeroCareSM can help Zorbtive patients
Helpful information for people with SBS, considering Zorbtive treatment
Clinical information about Zorbtive for health professionals
Clinical opinions about Zorbtive and goals of treatment for Short Bowel Syndrome
Glossary
Links
Home
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed.
Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling).
Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or
other blood sugar problems, pain, numbness or tingling in the wrist and hand, or increased blood pressure
in the brain. Make sure and talk with your doctor about these side effects.
Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications.
This information is not intended to replace discussions with your healthcare professional.
For additional information about Zorbtive, please read the Zorbtive Patient Information Leaflet
and Zorbtive Full Prescribing Information and talk to your doctor. You can also call SeroCareSM
toll free at 800-714-2437. Zorbtive is available by prescription only.
This Web site was developed by EMD Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS patients
and interested healthcare professionals about this treatment for Short Bowel Syndrome.
This site contains medical information that is intended for residents of the United States
only and is not meant to substitute for the advice provided by a medical professional.
Always consult a doctor if you have health concerns. Use and access of this
site is subject to the terms and conditions as set out in our Legal Statement
and Privacy Policy.
© 2007 EMD Serono, Inc. All rights reserved. 